Paragon 28 Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the fourth quarter 2024 to a ratio of 6.76, above the company average. This is a clear sign of healthy business climate in the Medical Equipment & Supplies industry and improving liquidity at their respective customers, during the fourth quarter 2024. Average receivable collection period, for the Paragon 28 Inc in Dec 31 2024 quarter, has decreased to 54 days, compared to 56 days, in the Sep 30 2024 quarter.

If we take a look into Healthcare sector 134 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 1255, from overall ranking in the third quarter 2024 at 1683.

What is Receivable Turnover Ratio?
What is Paragon 28 Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

FNA Receivables Turnover Ratio	(Dec 31 2024) IV. Quarter	(Sep 30 2024) III. Quarter	(Jun 30 2024) II. Quarter	(Mar 31 2024) I. Quarter	(Dec 31 2023) IV. Quarter
Y / Y Receivable Change	4.54 %	6.57 %	6.92 %	6.53 %	-0.97 %
Y / Y Revenue Change	20.53 %	18.68 %	19.11 %	15.77 %	16.49 %
Receivable Turnover Ratio (TTM)	6.76	6.5	6.34	6.17	6.05
FNA's Total Ranking	# 1255	# 1683	# 1085	# 1248	# 1251
Accounts Receivable average collection period days	54	56	58	59	60
Seq. Receivable Change	8.91 %	-2.41 %	-7.52 %	6.36 %	11.03 %
Seq. Revenue Change	16.31 %	2.34 %	0.85 %	0.4 %	14.53 %

Receivable Turnover Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 63
Healthcare Sector	# 135
Overall Market	# 1255

Receivable Turnover Ratio Statistics
High	Average	Low
0.83	0.67	0.37
(Dec 31 2024)		(Sep 30 2022)

FNA Company Profile • Back to FNA Efficiency Comparisons • Compare FNA Receivables Turnover Ratio to its Competitors

Financial Statements
Paragon 28 Inc 's Accounts Receivable	$ 39 Millions	Visit FNA's Balance sheet
Paragon 28 Inc 's Sales TTM	$ 255 Millions	Visit FNA's Income Statement
Sources of FNA's Revenues		Visit FNA's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
FNA's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
FNA's Growth Rates	FNA's Roa	FNA's Inventory Turnover Ratio	FNA's Dividend Comparisons
FNA's Profitability Ratios	FNA's Roi	FNA's Asset Turnover Ratio	FNA's Dividend Growth
FNA's Valuation Ratios	FNA's Roe	FNA's Financial Strength Ratios	FNA's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2024, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Dec 31 2024	Receivable at quarter ending Dec 31 2024
Lakeshore Biopharma Co Ltd	17.92	$ 80.820 Millions	$ 4.511 Millions
Silence Therapeutics Plc	17.91	$ 43.258 Millions	$ 2.416 Millions
Talkspace Inc	17.86	$ 186.836 Millions	$ 10.459 Millions
Vireo Growth Inc.	17.37	$ 99.384 Millions	$ 5.721 Millions
Generation Bio Co	16.67	$ 19.892 Millions	$ 1.193 Millions
Innovage Holding Corp	16.60	$ 806.613 Millions	$ 48.590 Millions
Kiniksa Pharmaceuticals International Plc	16.43	$ 423.239 Millions	$ 25.764 Millions
Milestone Scientific Inc	16.26	$ 8.435 Millions	$ 0.519 Millions
Gsk Plc	16.16	$ 31,376.000 Millions	$ 1,942.000 Millions
Hookipa Pharma inc	16.12	$ 43.946 Millions	$ 2.727 Millions
Voyager Therapeutics Inc	16.00	$ 80.001 Millions	$ 4.999 Millions
Stablecoin Development Corporation	15.97	$ 9.481 Millions	$ 0.594 Millions
Petvivo Holdings Inc	15.73	$ 0.956 Millions	$ 0.061 Millions
Mannkind Corporation	15.59	$ 285.504 Millions	$ 18.312 Millions
Medinotec Inc	15.50	$ 8.947 Millions	$ 0.577 Millions
Nexalin Technology Inc	15.48	$ 0.169 Millions	$ 0.011 Millions
Cervomed Inc	15.47	$ 9.738 Millions	$ 0.630 Millions
Waters Corporation	15.20	$ 2,958.387 Millions	$ 194.592 Millions
Biofrontera Inc	14.59	$ 63.395 Millions	$ 4.346 Millions
Icu Medical Inc	14.57	$ 2,382.046 Millions	$ 163.441 Millions
Sangamo Therapeutics Inc	14.13	$ 57.800 Millions	$ 4.092 Millions
Inmed Pharmaceuticals Inc	14.12	$ 4.494 Millions	$ 0.318 Millions
China Pharma Holdings Inc	13.76	$ 4.529 Millions	$ 0.329 Millions
Chemed Corporation	13.32	$ 2,431.287 Millions	$ 182.485 Millions
Qt Imaging Holdings Inc exact Name Of Registrant As Specified In Its Charter _______________________	13.23	$ 4.879 Millions	$ 0.369 Millions
Amylyx Pharmaceuticals Inc	13.13	$ 87.371 Millions	$ 6.655 Millions
Patterson Companies Inc	13.08	$ 6,511.680 Millions	$ 497.898 Millions
Qhslab Inc	12.98	$ 2.132 Millions	$ 0.164 Millions
Nrc Health	12.89	$ 143.060 Millions	$ 11.100 Millions
Rosecliff Acquisition Corp I	12.51	$ 29.581 Millions	$ 2.366 Millions

Date modified: 2026-09-08T15:11:27+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.